Lee JL - Search Results

1

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

Motzer RJ, Porta C, Vogelzang NJ, Sternberg CN, Szczylik C, Zolnierek J, Kollmannsberger C, Rha SY, Bjarnason GA, Melichar B, De Giorgi U, Grünwald V, Davis ID, Lee JL, Esteban E, Urbanowitz G, Cai C, Squires M, Marker M, Shi MM, Escudier B. Motzer RJ, et al. Among authors: lee jl. Lancet Oncol. 2014 Mar;15(3):286-96. doi: 10.1016/S1470-2045(14)70030-0. Epub 2014 Feb 17. Lancet Oncol. 2014. PMID: 24556040 Free PMC article. Clinical Trial.

2

Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.

Lee SS, Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Kim WK, Lee JS, Kang YK. Lee SS, et al. Among authors: lee js, lee jl. Jpn J Clin Oncol. 2007 Jan;37(1):30-7. doi: 10.1093/jjco/hyl134. Jpn J Clin Oncol. 2007. PMID: 17272321

3

Efficacy and safety of S-1 monotherapy in patients with advanced biliary tract adenocarcinoma: retrospective analysis of 162 patients.

Park I, Lee JL, Ryu MH, Kim TW, Chang HM, Lee SS, Sohn BS, Kim EK, Park DH, Lee SS, Suh DW, Lee SK, Kim MH, Lee J. Park I, et al. Among authors: lee sk, lee j, lee ss, lee jl. Oncology. 2009;76(2):126-32. doi: 10.1159/000195538. Epub 2009 Jan 22. Oncology. 2009. PMID: 19158445

4

The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.

Sohn BS, Kim TW, Lee JL, Ryu MH, Chang HM, Kang YK, Park HS, Na YS, Jang SJ, Kim JC, Lee JS. Sohn BS, et al. Among authors: lee js, lee jl. Oncology. 2009;77(3-4):224-30. doi: 10.1159/000236046. Epub 2009 Sep 7. Oncology. 2009. PMID: 19738388

5

The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reduction.

Yoo C, Kim JE, Lee JL, Ahn JH, Lee DH, Lee JS, Na S, Kim CS, Hong JH, Hong B, Song C, Ahn H. Yoo C, et al. Among authors: lee dh, lee js, lee jl. Jpn J Clin Oncol. 2010 Oct;40(10):980-5. doi: 10.1093/jjco/hyq073. Epub 2010 May 10. Jpn J Clin Oncol. 2010. PMID: 20457723 Clinical Trial.

6

Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer.

Kim C, Lee JL, Choi YH, Kang BW, Ryu MH, Chang HM, Kim TW, Kang YK. Kim C, et al. Among authors: lee jl. Invest New Drugs. 2012 Feb;30(1):306-15. doi: 10.1007/s10637-010-9531-2. Epub 2010 Sep 14. Invest New Drugs. 2012. PMID: 20839031 Clinical Trial.

7

The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.

You D, Jeong IG, Ahn JH, Lee DH, Lee JL, Hong JH, Ahn H, Kim CS. You D, et al. Among authors: lee dh, lee jl. J Urol. 2011 Jan;185(1):54-9. doi: 10.1016/j.juro.2010.09.018. Epub 2010 Nov 12. J Urol. 2011. PMID: 21074811

8

Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?

Yoo DJ, Kim KM, Jin YJ, Shim JH, Ko GY, Yoon HK, Sung KB, Lee JL, Kang YK, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Yoo DJ, et al. Among authors: lee hc, lee ys, lee jl. J Gastroenterol Hepatol. 2011 Jan;26(1):145-54. doi: 10.1111/j.1440-1746.2010.06341.x. J Gastroenterol Hepatol. 2011. PMID: 21175808

9

Adjuvant chemotherapy for small bowel adenocarcinoma after curative surgery.

Koo DH, Yun SC, Hong YS, Ryu MH, Lee JL, Chang HM, Kang YK, Kim SC, Han DJ, Lee YJ, Kim TW. Koo DH, et al. Among authors: lee yj, lee jl. Oncology. 2011;80(3-4):208-13. doi: 10.1159/000328506. Epub 2011 Jul 1. Oncology. 2011. PMID: 21720183

10

Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features.

Lee JL, Park I, Park K, Park S, Ahn Y, Ahn JH, Kim TW, Ahn S, Song C, Hong JH, Kim CS, Ahn H. Lee JL, et al. J Cancer Res Clin Oncol. 2012 Apr;138(4):687-93. doi: 10.1007/s00432-012-1148-8. Epub 2012 Jan 12. J Cancer Res Clin Oncol. 2012. PMID: 22237457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,099 results

Search Page

Filters